Pardin C - Search Results

1

Towards a characterization of the structural determinants of specificity in the macrocyclizing thioesterase for deoxyerythronolide B biosynthesis.

Argyropoulos P, Bergeret F, Pardin C, Reimer JM, Pinto A, Boddy CN, Schmeing TM. Argyropoulos P, et al. Among authors: pardin c. Biochim Biophys Acta. 2016 Mar;1860(3):486-97. doi: 10.1016/j.bbagen.2015.11.007. Epub 2015 Nov 22. Biochim Biophys Acta. 2016. PMID: 26592346

2

First-in-class small molecule potentiators of cancer virotherapy.

Dornan MH, Krishnan R, Macklin AM, Selman M, El Sayes N, Son HH, Davis C, Chen A, Keillor K, Le PJ, Moi C, Ou P, Pardin C, Canez CR, Le Boeuf F, Bell JC, Smith JC, Diallo JS, Boddy CN. Dornan MH, et al. Among authors: pardin c. Sci Rep. 2016 May 26;6:26786. doi: 10.1038/srep26786. Sci Rep. 2016. PMID: 27226390 Free PMC article.

3

Site-specific protein labelling and immobilization mediated by microbial transglutaminase.

Oteng-Pabi SK, Pardin C, Stoica M, Keillor JW. Oteng-Pabi SK, et al. Among authors: pardin c. Chem Commun (Camb). 2014 Jun 25;50(50):6604-6. doi: 10.1039/c4cc00994k. Chem Commun (Camb). 2014. PMID: 24824734

4

Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.

Pardin C, Roy I, Lubell WD, Keillor JW. Pardin C, et al. Chem Biol Drug Des. 2008 Sep;72(3):189-96. doi: 10.1111/j.1747-0285.2008.00696.x. Epub 2008 Aug 19. Chem Biol Drug Des. 2008. PMID: 18715232

5

Development of new scaffolds as reversible tissue transglutaminase inhibitors, with improved potency or resistance to glutathione addition.

Apperley KYP, Roy I, Saucier V, Brunet-Filion N, Piscopo SP, Pardin C, De Francesco É, Hao C, Keillor JW. Apperley KYP, et al. Among authors: pardin c. Medchemcomm. 2016 Dec 5;8(2):338-345. doi: 10.1039/c6md00565a. eCollection 2017 Feb 1. Medchemcomm. 2016. PMID: 30108749 Free PMC article.

6

Synthesis and evaluation of peptidic irreversible inhibitors of tissue transglutaminase.

Pardin C, Gillet SM, Keillor JW. Pardin C, et al. Bioorg Med Chem. 2006 Dec 15;14(24):8379-85. doi: 10.1016/j.bmc.2006.09.011. Epub 2006 Sep 27. Bioorg Med Chem. 2006. PMID: 17008102

7

Cinnamoyl inhibitors of tissue transglutaminase.

Pardin C, Pelletier JN, Lubell WD, Keillor JW. Pardin C, et al. J Org Chem. 2008 Aug 1;73(15):5766-75. doi: 10.1021/jo8004843. Epub 2008 Jun 27. J Org Chem. 2008. PMID: 18582115

8

Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors.

Pardin C, Roy I, Chica RA, Bonneil E, Thibault P, Lubell WD, Pelletier JN, Keillor JW. Pardin C, et al. Biochemistry. 2009 Apr 21;48(15):3346-53. doi: 10.1021/bi802021c. Biochemistry. 2009. PMID: 19271761

9

Uncovering new properties of imidazolium salts: Cl- transport and supramolecular regulation of their transmembrane activity.

Elie CR, Noujeim N, Pardin C, Schmitzer AR. Elie CR, et al. Among authors: pardin c. Chem Commun (Camb). 2011 Feb 14;47(6):1788-90. doi: 10.1039/c0cc04280c. Epub 2010 Dec 3. Chem Commun (Camb). 2011. PMID: 21132159

10

Irreversible inhibitors of tissue transglutaminase.

Keillor JW, Chabot N, Roy I, Mulani A, Leogane O, Pardin C. Keillor JW, et al. Among authors: pardin c. Adv Enzymol Relat Areas Mol Biol. 2011;78:415-47. doi: 10.1002/9781118105771.ch10. Adv Enzymol Relat Areas Mol Biol. 2011. PMID: 22220480 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page